Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Simvastatin attenuates the oxidative stress, endothelial thrombogenicity and the inducibility of atrial fibrillation in a rat model of ischemic heart failure.

Cho KI, Koo SH, Cha TJ, Heo JH, Kim HS, Jo GB, Lee JW.

Int J Mol Sci. 2014 Aug 22;15(8):14803-18. doi: 10.3390/ijms150814803.

2.

An Angiotensin receptor blocker prevents arrhythmogenic left atrial remodeling in a rat post myocardial infarction induced heart failure model.

Kim HS, No CW, Goo SH, Cha TJ.

J Korean Med Sci. 2013 May;28(5):700-8. doi: 10.3346/jkms.2013.28.5.700.

3.

Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury.

Yagi S, Akaike M, Aihara K, Ishikawa K, Iwase T, Ikeda Y, Soeki T, Yoshida S, Sumitomo-Ueda Y, Matsumoto T, Sata M.

Hypertension. 2010 Apr;55(4):918-23. doi: 10.1161/HYPERTENSIONAHA.109.146076.

4.

Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure.

Shiroshita-Takeshita A, Brundel BJ, Burstein B, Leung TK, Mitamura H, Ogawa S, Nattel S.

Cardiovasc Res. 2007 Apr 1;74(1):75-84.

PMID:
17270161
5.

Thyroid hormone replacement therapy attenuates atrial remodeling and reduces atrial fibrillation inducibility in a rat myocardial infarction-heart failure model.

Zhang Y, Dedkov EI, Lee B 3rd, Li Y, Pun K, Gerdes AM.

J Card Fail. 2014 Dec;20(12):1012-9. doi: 10.1016/j.cardfail.2014.10.003.

6.

The β3 Adrenergic Receptor Agonist BRL37344 Exacerbates Atrial Structural Remodeling Through iNOS Uncoupling in Canine Models of Atrial Fibrillation.

Wang X, Wang R, Liu G, Dong J, Zhao G, Tian J, Sun J, Jia X, Wei L, Wang Y, Li W.

Cell Physiol Biochem. 2016;38(2):514-30. doi: 10.1159/000438647.

7.

Role for MicroRNA-21 in atrial profibrillatory fibrotic remodeling associated with experimental postinfarction heart failure.

Cardin S, Guasch E, Luo X, Naud P, Le Quang K, Shi Y, Tardif JC, Comtois P, Nattel S.

Circ Arrhythm Electrophysiol. 2012 Oct;5(5):1027-35. doi: 10.1161/CIRCEP.112.973214.

8.

Simvastatin improves left ventricular function after myocardial infarction in hypercholesterolemic rabbits by anti-inflammatory effects.

Bauersachs J, Hiss K, Fraccarollo D, Laufs U, Ruetten H.

Cardiovasc Res. 2006 Dec 1;72(3):438-46.

PMID:
17026973
9.

Simvastatin ameliorates liver fibrosis via mediating nitric oxide synthase in rats with non-alcoholic steatohepatitis-related liver fibrosis.

Wang W, Zhao C, Zhou J, Zhen Z, Wang Y, Shen C.

PLoS One. 2013 Oct 2;8(10):e76538. doi: 10.1371/journal.pone.0076538.

10.

Resveratrol, a red wine antioxidant, reduces atrial fibrillation susceptibility in the failing heart by PI3K/AKT/eNOS signaling pathway activation.

Chong E, Chang SL, Hsiao YW, Singhal R, Liu SH, Leha T, Lin WY, Hsu CP, Chen YC, Chen YJ, Wu TJ, Higa S, Chen SA.

Heart Rhythm. 2015 May;12(5):1046-56. doi: 10.1016/j.hrthm.2015.01.044.

PMID:
25640634
11.

Nitric oxide overproduction derived from inducible nitric oxide synthase increases cardiomyocyte apoptosis in human atrial fibrillation.

Han W, Fu S, Wei N, Xie B, Li W, Yang S, Li Y, Liang Z, Huo H.

Int J Cardiol. 2008 Nov 12;130(2):165-73. doi: 10.1016/j.ijcard.2008.02.026.

PMID:
18585800
12.

Simvastatin attenuates sympathetic hyperinnervation to prevent atrial fibrillation during the postmyocardial infarction remodeling process.

Yu T, Zhu W, Gu B, Li S, Wang F, Liu M, Wei M, Li J.

J Appl Physiol (1985). 2012 Dec 15;113(12):1937-44. doi: 10.1152/japplphysiol.00451.2012.

13.

Practical prevention of cardiac remodeling and atrial fibrillation with full-spectrum antioxidant therapy and ancillary strategies.

McCarty MF.

Med Hypotheses. 2010 Aug;75(2):141-7. doi: 10.1016/j.mehy.2009.12.025. Review.

PMID:
20083360
14.

[The experimental study on changes of endothelial nitric oxide synthase and plasminogen activator inhibitor-1 protein in the canine atrial fibrillation model].

Han W, Li WM, Song LY, Li Y, Yang SS, Huang YL, Gan RT, Kou JJ, Geng JQ.

Zhonghua Xin Xue Guan Bing Za Zhi. 2005 Jan;33(1):69-72. Chinese.

PMID:
15924787
15.

Alogliptin, a dipeptidyl peptidase-4 inhibitor, regulates the atrial arrhythmogenic substrate in rabbits.

Yamamoto T, Shimano M, Inden Y, Takefuji M, Yanagisawa S, Yoshida N, Tsuji Y, Hirai M, Murohara T.

Heart Rhythm. 2015 Jun;12(6):1362-9. doi: 10.1016/j.hrthm.2015.03.010.

PMID:
25757661
16.

Effect of Pneumoperitoneum on Oxidative Stress and Inflammation via the Arginase Pathway in Rats.

Shin S, Na S, Kim OS, Choi YS, Kim SH, Oh YJ.

Yonsei Med J. 2016 Jan;57(1):238-46. doi: 10.3349/ymj.2016.57.1.238.

17.

Angiotensin type 1 receptor blockade prevents endocardial dysfunction of rapidly paced atria in rats.

Yamashita T, Sekiguchi A, Kato T, Tsuneda T, Iwasaki YK, Sagara K, Iinuma H, Sawada H, Aizawa T.

J Renin Angiotensin Aldosterone Syst. 2007 Sep;8(3):127-32.

PMID:
17907100
18.

Role of mineralocorticoid receptor on atrial structural remodeling and inducibility of atrial fibrillation in hypertensive rats.

Kimura S, Ito M, Tomita M, Hoyano M, Obata H, Ding L, Chinushi M, Hanawa H, Kodama M, Aizawa Y.

Hypertens Res. 2011 May;34(5):584-91. doi: 10.1038/hr.2010.277.

PMID:
21248754
19.

Atrial endothelial impairment through Toll-like receptor 4 signaling causes atrial thrombogenesis.

Katoh S, Honda S, Watanabe T, Suzuki S, Ishino M, Kitahara T, Funayama A, Netsu S, Sasaki T, Shishido T, Miyamoto T, Sadahiro M, Kubota I.

Heart Vessels. 2014 Mar;29(2):263-72. doi: 10.1007/s00380-013-0369-3.

PMID:
23754516
20.

Enhanced nitric oxide bioavailability in coronary arteries prevents the onset of heart failure in rats with myocardial infarction.

Couto GK, Britto LR, Mill JG, Rossoni LV.

J Mol Cell Cardiol. 2015 Sep;86:110-20. doi: 10.1016/j.yjmcc.2015.07.017.

PMID:
26225841
Items per page

Supplemental Content

Support Center